A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors
Clinical trial NCT02571569 · COMPLETED
Trial details
- NCT number
- NCT02571569
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-28
- Primary completion
- 2018-07-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.